These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 21533328

  • 1. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, Pulte I.
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R.
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [Abstract] [Full Text] [Related]

  • 3. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.
    Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.
    Arch Phys Med Rehabil; 2008 May; 89(5):799-806. PubMed ID: 18452724
    [Abstract] [Full Text] [Related]

  • 4. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C, Botox Post-Stroke Spasticity Study Group.
    N Engl J Med; 2002 Aug 08; 347(6):395-400. PubMed ID: 12167681
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of NABOTA in post-stroke upper limb spasticity: a phase 3 multicenter, double-blinded, randomized controlled trial.
    Nam HS, Park YG, Paik NJ, Oh BM, Chun MH, Yang HE, Kim DH, Yi Y, Seo HG, Kim KD, Chang MC, Ryu JH, Lee SU.
    J Neurol Sci; 2015 Oct 15; 357(1-2):192-7. PubMed ID: 26233808
    [Abstract] [Full Text] [Related]

  • 6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R, Akturk S, Ersoy Y.
    Eur J Phys Rehabil Med; 2018 Oct 15; 54(5):738-744. PubMed ID: 29422486
    [Abstract] [Full Text] [Related]

  • 7. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, GSK1358820 Spasticity Study Group.
    Curr Med Res Opin; 2010 Aug 15; 26(8):1983-92. PubMed ID: 20569068
    [Abstract] [Full Text] [Related]

  • 8. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A, Micello MF, Panza F, Fortunato F, Baricich A, Cisari C, Pilotto A, Logroscino G, Fiore P, Ranieri M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):39-43. PubMed ID: 25263601
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J, Bogucki A, Reclawowicz D.
    Neurol Sci; 2005 Apr 15; 26(1):32-9. PubMed ID: 15877185
    [Abstract] [Full Text] [Related]

  • 10. Can botulinum toxin decrease carer burden in long term care residents with upper limb spasticity? A randomized controlled study.
    Lam K, Lau KK, So KK, Tam CK, Wu YM, Cheung G, Liang KS, Yeung KM, Lam KY, Yui S, Leung C.
    J Am Med Dir Assoc; 2012 Jun 15; 13(5):477-84. PubMed ID: 22521630
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of letibotulinumtoxinA(BOTULAX®) in treatment of post stroke upper limb spasticity: a randomized, double blind, multi-center, phase III clinical trial.
    Do KH, Chun MH, Paik NJ, Park YG, Lee SU, Kim MW, Kim DK.
    Clin Rehabil; 2017 Sep 15; 31(9):1179-1188. PubMed ID: 28118733
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial.
    Gracies JM, Brashear A, Jech R, McAllister P, Banach M, Valkovic P, Walker H, Marciniak C, Deltombe T, Skoromets A, Khatkova S, Edgley S, Gul F, Catus F, De Fer BB, Vilain C, Picaut P, International AbobotulinumtoxinA Adult Upper Limb Spasticity Study Group.
    Lancet Neurol; 2015 Oct 15; 14(10):992-1001. PubMed ID: 26318836
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of OnabotulinumtoxinA 400 Units in Patients with Post-Stroke Upper Limb Spasticity: Final Report of a Randomized, Double-Blind, Placebo-Controlled Trial with an Open-Label Extension Phase.
    Abo M, Shigematsu T, Hara H, Matsuda Y, Nimura A, Yamashita Y, Takahashi K.
    Toxins (Basel); 2020 Feb 18; 12(2):. PubMed ID: 32085529
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. IncobotulinumtoxinA Efficacy and Safety in Adults with Upper-Limb Spasticity Following Stroke: Results from the Open-Label Extension Period of a Phase 3 Study.
    Marciniak C, Munin MC, Brashear A, Rubin BS, Patel AT, Slawek J, Hanschmann A, Hiersemenzel R, Elovic EP.
    Adv Ther; 2019 Jan 18; 36(1):187-199. PubMed ID: 30484117
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of botulinum neurotoxin NT 201 in poststroke upper limb spasticity.
    Kanovský P, Slawek J, Denes Z, Platz T, Sassin I, Comes G, Grafe S.
    Clin Neuropharmacol; 2009 Jan 18; 32(5):259-65. PubMed ID: 19644361
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of incobotulinumtoxinA in post-stroke upper-limb spasticity in Japanese subjects: results from a randomized, double-blind, placebo-controlled study (J-PURE).
    Masakado Y, Abo M, Kondo K, Saeki S, Saitoh E, Dekundy A, Hanschmann A, Kaji R, J-PURE Study Group.
    J Neurol; 2020 Jul 18; 267(7):2029-2041. PubMed ID: 32219557
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of botulinum toxin type A (Dysport) for the treatment of post-stroke arm spasticity: results of the German-Austrian open-label post-marketing surveillance prospective study.
    Jost WH, Hefter H, Reissig A, Kollewe K, Wissel J.
    J Neurol Sci; 2014 Feb 15; 337(1-2):86-90. PubMed ID: 24361062
    [Abstract] [Full Text] [Related]

  • 20. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke.
    Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C.
    Stroke; 2000 Oct 15; 31(10):2402-6. PubMed ID: 11022071
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.